{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:06:00Z","timestamp":1784660760528,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP22H02982"],"award-info":[{"award-number":["JP22H02982"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP24K18683"],"award-info":[{"award-number":["JP24K18683"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H04067"],"award-info":[{"award-number":["JP23H04067"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP23H00420"],"award-info":[{"award-number":["JP23H00420"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP21H05025"],"award-info":[{"award-number":["JP21H05025"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP25H01414"],"award-info":[{"award-number":["JP25H01414"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP22am0401007"],"award-info":[{"award-number":["JP22am0401007"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP25bm1423003"],"award-info":[{"award-number":["JP25bm1423003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP24ae0121056"],"award-info":[{"award-number":["JP24ae0121056"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"publisher","award":["JP22nk0101575"],"award-info":[{"award-number":["JP22nk0101575"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omtn.2025.102802","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:33:22Z","timestamp":1765499602000},"page":"102802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment"],"prefix":"10.1016","volume":"37","author":[{"given":"Kentaro","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoki","family":"Hirunagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Sahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madoka","family":"Iida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sakakibara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Onodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manabu","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Asanuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9453-9311","authenticated-orcid":false,"given":"Masahisa","family":"Katsuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102802_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathmechdis-012418-012857","article-title":"Polyglutamine repeats in neurodegenerative diseases","volume":"14","author":"Lieberman","year":"2019","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.omtn.2025.102802_bib2","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy","volume":"352","author":"La Spada","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102802_bib3","series-title":"Pathogenesis of Polyglutamine Diseases","author":"Sahashi","year":"2018"},{"key":"10.1016\/j.omtn.2025.102802_bib4","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMc2300400","article-title":"Tominersen in adults with manifest Huntington\u2019s disease","volume":"389","author":"McColgan","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102802_bib5","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JHD-229003","article-title":"Perspective: Tominersen testing finds a way forward","volume":"11","author":"Aronin","year":"2022","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.omtn.2025.102802_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25073984","article-title":"Spinocerebellar ataxia type 3 pathophysiology-implications for translational research and clinical studies","volume":"25","author":"Stahl","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102802_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/d41586-021-01177-7","article-title":"Failure of genetic therapies for Huntington\u2019s devastates community","volume":"593","author":"Kwon","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102802_bib8","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1093\/hmg\/ddg344","article-title":"The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity","volume":"12","author":"Burnett","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102802_bib9","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1093\/brain\/awr047","article-title":"Overexpression of the autophagic beclin-1 protein clears mutant ataxin-3 and alleviates Machado-Joseph disease","volume":"134","author":"Nascimento-Ferreira","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.omtn.2025.102802_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1074\/jbc.RA118.005801","article-title":"Physiological and pathophysiological characteristics of ataxin-3 isoforms","volume":"294","author":"Weish\u00e4upl","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2025.102802_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2015.05.010","article-title":"The deubiquitinase ataxin-3 requires Rad23 and DnaJ-1 for its neuroprotective role in Drosophila melanogaster","volume":"82","author":"Tsou","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.omtn.2025.102802_bib12","doi-asserted-by":"crossref","first-page":"34460","DOI":"10.1074\/jbc.M113.513903","article-title":"Ubiquitination regulates the neuroprotective function of the deubiquitinase ataxin-3 in vivo","volume":"288","author":"Tsou","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.omtn.2025.102802_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.molcel.2005.02.030","article-title":"Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism","volume":"18","author":"Warrick","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2025.102802_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtn.2024.102246","article-title":"Preclinical evaluation of stereopure antisense oligonucleotides for allele-selective lowering of mutant HTT","volume":"35","author":"Iwamoto","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102802_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.omtn.2021.11.015","article-title":"Allele-specific targeting of mutant ataxin-3 by antisense oligonucleotides in SCA3-iPSC-derived neurons","volume":"27","author":"Hauser","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102802_bib16","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.omtn.2019.07.004","article-title":"Suppression of mutant protein expression in SCA3 and SCA1 mice using a CAG repeat-targeting antisense oligonucleotide","volume":"17","author":"Kourkouta","year":"2019","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102802_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0171127","article-title":"The expanded CAG repeat in the huntingtin gene as target for therapeutic RNA modulation throughout the HD mouse brain","volume":"12","author":"Datson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omtn.2025.102802_bib18","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1172\/JCI83185","article-title":"Targeting CAG repeat RNAs reduces Huntington\u2019s disease phenotype independently of huntingtin levels","volume":"126","author":"Ru\u00e9","year":"2016","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.omtn.2025.102802_bib19","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1021\/bi500610r","article-title":"Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs","volume":"53","author":"Hu","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2025.102802_bib20","doi-asserted-by":"crossref","first-page":"8788","DOI":"10.1093\/nar\/gkt594","article-title":"RNA duplexes with abasic substitutions are potent and allele-selective inhibitors of huntingtin and ataxin-3 expression","volume":"41","author":"Liu","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102802_bib21","doi-asserted-by":"crossref","first-page":"9329","DOI":"10.1021\/bi4014209","article-title":"Allele-selective inhibition of expression of huntingtin and ataxin-3 by RNA duplexes containing unlocked nucleic acid substitutions","volume":"52","author":"Aiba","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.omtn.2025.102802_bib22","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.chembiol.2010.10.013","article-title":"Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism","volume":"17","author":"Hu","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.omtn.2025.102802_bib23","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1093\/nar\/gkr156","article-title":"Inhibition of mutant huntingtin expression by RNA duplex targeting expanded CAG repeats","volume":"39","author":"Fiszer","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102802_bib24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaneurol.2019.0423","article-title":"Prevalence of carriers of intermediate and pathological polyglutamine disease-associated alleles among large population-based cohorts","volume":"76","author":"Gardiner","year":"2019","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.omtn.2025.102802_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2021.02.007","article-title":"Selective suppression of polyglutamine-expanded protein by lipid nanoparticle-delivered siRNA targeting CAG expansions in the mouse CNS","volume":"24","author":"Hirunagi","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102802_bib26","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1002\/cbic.201402369","article-title":"Enhancement of stability and activity of siRNA by terminal substitution with serinol nucleic acid (SNA)","volume":"15","author":"Kamiya","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/j.omtn.2025.102802_bib27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1002\/anie.201006498","article-title":"Control of the chirality and helicity of oligomers of serinol nucleic acid (SNA) by sequence design","volume":"50","author":"Kashida","year":"2011","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.omtn.2025.102802_bib28","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.3390\/ijms21155218","article-title":"Investigation of strand-selective interaction of SNA-modified siRNA with AGO2-MID","volume":"21","author":"Kamiya","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2025.102802_bib29","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nature08434","article-title":"Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes","volume":"461","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.omtn.2025.102802_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0896-6273(02)00834-6","article-title":"Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"35","author":"Katsuno","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2025.102802_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2025.102802_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.ymthe.2024.02.033","article-title":"ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice","volume":"32","author":"Schuster","year":"2024","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102802_bib33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","article-title":"Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models","volume":"7","author":"Moore","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102802_bib34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.omtn.2017.06.019","article-title":"Antisense oligonucleotide-mediated removal of the polyglutamine repeat in spinocerebellar ataxia type 3 mice","volume":"8","author":"Toonen","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102802_bib35","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/11.9.1075","article-title":"YAC transgenic mice carrying pathological alleles of the MJD1 locus exhibit a mild and slowly progressive cerebellar deficit","volume":"11","author":"Cemal","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102802_bib36","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1750-3639.1998.tb00193.x","article-title":"An isoform of ataxin-3 accumulates in the nucleus of neuronal cells in affected brain regions of SCA3 patients","volume":"8","author":"Schmidt","year":"1998","journal-title":"Brain Pathol."},{"key":"10.1016\/j.omtn.2025.102802_bib37","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ana.410410408","article-title":"Machado-Joseph disease gene product is a cytoplasmic protein widely expressed in brain","volume":"41","author":"Paulson","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.omtn.2025.102802_bib38","doi-asserted-by":"crossref","first-page":"7418","DOI":"10.1523\/JNEUROSCI.4540-06.2007","article-title":"Nuclear localization of ataxin-3 is required for the manifestation of symptoms in SCA3: in vivo evidence","volume":"27","author":"Bichelmeier","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2025.102802_bib39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2025.102802_bib40","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1523\/JNEUROSCI.1870-13.2014","article-title":"The regulation of autophagosome dynamics by huntingtin and HAP1 is disrupted by expression of mutant huntingtin, leading to defective cargo degradation","volume":"34","author":"Wong","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2025.102802_bib41","doi-asserted-by":"crossref","first-page":"10045","DOI":"10.1073\/pnas.0610628104","article-title":"Huntingtin facilitates dynein\/dynactin-mediated vesicle transport","volume":"104","author":"Caviston","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102802_bib42","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/nrn1806","article-title":"Normal huntingtin function: an alternative approach to Huntington\u2019s disease","volume":"6","author":"Cattaneo","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.omtn.2025.102802_bib43","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1073\/pnas.0407252102","article-title":"The polyglutamine neurodegenerative protein ataxin 3 regulates aggresome formation","volume":"102","author":"Burnett","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2025.102802_bib44","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/mt.2011.201","article-title":"Potent and selective antisense oligonucleotides targeting single-nucleotide polymorphisms in the Huntington disease gene\/allele-specific silencing of mutant huntingtin","volume":"19","author":"Carroll","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102802_bib45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1177\/18796397241293955","article-title":"Huntington\u2019s Disease Clinical Trials Update: September 2024","volume":"13","author":"Farag","year":"2024","journal-title":"J. Huntingtons Dis."},{"key":"10.1016\/j.omtn.2025.102802_bib46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF02257483","article-title":"Structure and expression of the Huntington\u2019s disease gene: evidence against simple inactivation due to an expanded CAG repeat","volume":"20","author":"Ambrose","year":"1994","journal-title":"Somatic Cell Genet."},{"key":"10.1016\/j.omtn.2025.102802_bib47","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/hmg\/ddl072","article-title":"Body weight is modulated by levels of full-length huntingtin","volume":"15","author":"Van Raamsdonk","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102802_bib48","doi-asserted-by":"crossref","first-page":"5508","DOI":"10.1523\/JNEUROSCI.18-14-05508.1998","article-title":"Mice lacking ataxin-1 display learning deficits and decreased hippocampal paired-pulse facilitation","volume":"18","author":"Matilla","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2025.102802_bib49","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s12017-010-8137-3","article-title":"Mouse ataxin-3 functional knock-out model","volume":"13","author":"Switonski","year":"2011","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.omtn.2025.102802_bib50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.celrep.2014.02.008","article-title":"Peripheral androgen receptor gene suppression rescues disease in mouse models of spinal and bulbar muscular atrophy","volume":"7","author":"Lieberman","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.omtn.2025.102802_bib51","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.neuron.2014.03.001","article-title":"Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy","volume":"82","author":"Cortes","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.omtn.2025.102802_bib52","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41587-019-0205-0","article-title":"A divalent siRNA chemical scaffold for potent and sustained modulation of gene expression throughout the central nervous system","volume":"37","author":"Alterman","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102802_bib53","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/alz.13703","article-title":"Silencing Apoe with divalent-siRNAs improves amyloid burden and activates immune response pathways in Alzheimer\u2019s disease","volume":"20","author":"Ferguson","year":"2024","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.omtn.2025.102802_bib54","article-title":"RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS mice","author":"Weiss","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102802_bib55","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41587-022-01334-x","article-title":"Expanding RNAi therapeutics to extrahepatic tissues with lipophilic conjugates","volume":"40","author":"Brown","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.omtn.2025.102802_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13041-020-0561-1","article-title":"Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs","volume":"13","author":"Onodera","year":"2020","journal-title":"Mol. Brain"},{"key":"10.1016\/j.omtn.2025.102802_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12282-7","article-title":"Src inhibition attenuates polyglutamine-mediated neuromuscular degeneration in spinal and bulbar muscular atrophy","volume":"10","author":"Iida","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102802_bib58","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"13","author":"Minamiyama","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102802_bib59","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jcsm.13344","article-title":"Exercise attenuates polyglutamine-mediated neuromuscular degeneration in a mouse model of spinal and bulbar muscular atrophy","volume":"15","author":"Hirunagi","year":"2024","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.omtn.2025.102802_bib60","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1101\/gad.197418.112","article-title":"TSUNAMI: An antisense method to phenocopy splicing-associated diseases in animals","volume":"26","author":"Sahashi","year":"2012","journal-title":"Genes Dev."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:15:49Z","timestamp":1780103749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125003567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2162253125003567"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102802","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An acyclic nucleic acid-modified siRNA targeting CAG expansions for polyglutamine disease treatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102802"}}